Moderna increases manufacturing capacity

By The Science Advisory Board staff writers

May 4, 2021 -- Moderna has doubled the size of its manufacturing technology center in Norwood, MA, expanding the facility from a production and lab space into an industrial technology center, according to the company.

Moderna's production lab and space has been increased from approximately 300,000 sq ft to approximately 650,000 sq ft. In addition, the firm acquired a 240,000-sq-ft building on the same campus in order to expand its commercial and clinical activities.

The expansion will enable a 50% increase in production of Moderna's COVID-19 vaccine at the manufacturing site beginning in late 2021 and early 2022, according to the company. Late last month, Moderna also announced investments in its owned and partnered manufacturing facilities that it expects would increase 2022 global capacity to up to 3 billion doses of its COVID-19 vaccine. It also raised its 2021 manufacturing supply forecast to be between 800 million and 1 billion doses.

Moderna secures WHO emergency use listing for COVID-19 vaccine
Moderna has secured emergency use listing from the World Health Organization (WHO) for its COVID-19 vaccine.
DNA Script, Moderna to develop on-demand vaccines, therapeutics
DNA Script and Moderna have announced a partnership to develop on-demand vaccines and therapeutics as part of the U.S. Defense Advanced Research Projects...
Sanofi to provide fill/finish services for Moderna COVID-19 vaccine
Moderna has inked a new agreement with Sanofi in order to scale up U.S. manufacturing capacity for its COVID-19 vaccine.
Moderna provides updates on mRNA vaccine platform
Moderna gave updates on its messenger RNA (mRNA) vaccines during its second annual Vaccines Day event. The company plans to continue to invest resources...
Moderna highlights 6-month antibody persistence of its COVID-19 vaccine
Antibody persistence lasted through six months following the second dose of Moderna's COVID-19 vaccine, according to a study published April 6 in the...

Copyright © 2021

Science Advisory Board on LinkedIn
Science Advisory Board on Facebook
Science Advisory Board on Twitter